Outcome of Board Meeting

www.capillarytech.com Date: November 02, 2026 To, To, BSE Limited National Stock Exchange of India Limited Listing Department Listing Department Phiroze JeeJeebhoy Towers, Dalal Exchange Plaza , Bandra Kurla Complex Street Fort, Mumbai -400001 Bandra (East), Mumbai -4000051 Scrip Code: 544614 Symbol: CAPILLARY Dear Sir/Madam, Subject: Outcome of Board Meeting held on November 02, 2026. Pursuant to Regulations 30, 33 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors of Capillary Technologies India Limited (the “Company”), at its meeting held today, i.e., November 02, 2026, has, inter alia, considered and approved the following, based on the recommendation of the Audit Committee: 1. The Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026 (“Financial Results”). The Board also took on record the Limited Review Report issued by the Statutory Auditors on the Financial Results. 2. The appointment of M/s. Deloitte Touche Tohmatsu India LLP as the Internal Auditor of the Company, in place of M/s. Protiviti India Member Private Limited, with effect from November 02, 2026. The details required under Regulation 30 of the SEBI Listing Regulations read with the SEBI Master Circular are enclosed as Annexure A. A copy of the Financial Results, along with the Limited Review Report, is enclosed. The Meeting of the board of directors of the Company commenced at 10:00 AM (IST) and concluded at 11:40 AM (IST). Further, in continuation to our earlier intimation dated September 24, 2026, regarding closure of trading window, we wish to inform you that the trading window for dealing in the securities of the Company has been closed from October 01, 2026, and shall re-open after 48 hours from the declaration of the financial results of the Company. This outcome of Board Meeting will also be made available on the website of the Company at: https://www.capillarytech.com/investors/shareholder-information/corporate- announcements/2026-27/ We request you to take the above information on records. Yours faithfully, For Capillary Technologies India Limited Gireddy Bhargavi Reddy Company Secretary and Compliance Officer Membership No. A17091 Place: Bengaluru Capillary Technologies India Limited CIN- L72200KA2012PLC063060 Regd. Office - 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru, Karnataka 560102 Email: secretarial@capillarytech.com Website: www.capillarytech.com Tel: 080-41225179 www.capillarytech.com Annexure A Change of Internal Auditor Sr. Details of Events that need to be Cessation Appointment No provided of M/s. Protiviti India Member of M/s. Deloitte Touche Private Limited as Internal Tohmatsu India LLP as the Auditor of the Company Internal Auditor of the Company a) Reason for change viz. Cessation consequent to the Appointment as Internal appointment, / reappointment, appointment of M/s. Deloitte Auditor of the Company, in resignation, removal, death or Touche Tohmatsu India LLP as view of the growing scale and otherwise Internal Auditor of the Company, complexity of the Company’s pursuant to the decision of the operations, including its Board, on the recommendation of overseas subsidiaries, and to the Audit Committee, to engage a further strengthen the firm with a global network to Company’s internal control, risk cover the expanding scale and management and governance international operations of the framework by engaging a firm Company. with a global network and specialised expertise in internal audit b) Date of Date of cessation –November 02, Date of appointment – appointment/reappointment/ 2026 November 02, 2026 cessation (as applicable) & term of Appointment/ reappointment; c) Brief profile (in case of Not Applicable M/s. Deloitte Touche Tohmatsu appointment); India LLP (LLPIN: AAE-8458) is a limited liability partnership registered in India and a member firm of the global Deloitte network, one of the Big Fou professional services firms. The firm provides audit, consulting, risk advisory and tax services, and has extensive experience in internal audit and internal financial controls for listed companies. d) Disclosure of relationships Not Applicable Not Applicable between directors (in case of appointment of a director). Capillary Technologies India Limited CIN- L72200KA2012PLC063060 Regd. Office - 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru, Karnataka 560102 Email: secretarial@capillarytech.com Website: www.capillarytech.com Tel: 080-41225179 Walker Chandiok & Co LLP 5th Floor, 65/2, Block “A”, Bagmane Tridib, Bagmane Tech Park, CV Raman Nagar, Bengaluru 560093 Karnataka, India T +91 80 4243 0700 F +91 80 4126 1228 Independent Auditor’s Review Report on the Standalone Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Capillary Technologies India Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results (‘the Statement’) of Capillary Technologies India Limited (‘the Company’) for the quarter ended 30 September 2026 and the year to date results for the period 01 April 2026 to 30 September 2026, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015 (as amended) (‘Listing Regulations’). Attention is drawn to the fact that the figures for the corresponding quarte r ended 30 September 2025 have been approved by the Company’s Board of Directors, but have not been subjected to audit or review. 2. The Statement, which is the responsibility of the Company’s management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (‘Ind AS 34’), prescribed under Section 133 of the Companies Act, 2013 (‘the Act’), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under Section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Chartered Accountants Walker Chandiok & Co LLP is registered with limited liability with identification Offices in Ahmedabad, Bengaluru, Chandigarh, Chennai, Dehradun, Goa, Gurugram, Hyderabad, Indore, Kochi, Kolkata, Mumbai, number AAC-2085 and has its registered New Delhi, Noida and Pune office at L-41 Connaught Circus, Outer Circle, New Delhi, 110001, India Independent Auditor’s Review Report on the Standalone Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (Cont’d) 4. Based on our review conducted as [Showing first 8,000 characters — download PDF for full document]